Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Alector, Inc. (ALEC) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Alector, Inc. (ALEC), most recent 12 months reported: revenue $13.86M, net loss $117.85M, free cash flow -$158.39M. Latest balance sheet on file: liquid cash $172.8M, total debt $9.85M, net cash $162.95M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Metagenomi Therapeutics, Inc. · LENZ THERAPEUTICS, INC. · X4 PHARMACEUTICALS, INC · Alpha Cognition Inc. · CRISPR THERAPEUTICS AG · Lineage Cell Therapeutics, Inc. · ELUTIA INC. · Surrozen, Inc./DE

Stock screener

Watchlist